Anthony Ting
Corporate Officer/Principal en International Society For Cell & Gene Therapy .
Origen de la red de primer grado Anthony Ting.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
International Society For Cell & Gene Therapy
1
| Non-Profit Organization | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anthony Ting a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University College London | College/University | Corporate Officer/Principal | |
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Royal Free London NHS Foundation Trust
 Royal Free London NHS Foundation Trust Hospital/Nursing ManagementHealth Services Royal Free London NHS Foundation Trust operates hospitals and clinics. The company was founded on July 1, 2014 and is headquartered in London, the United Kingdom. | Hospital/Nursing Management | Corporate Officer/Principal | |
| St Bartholomew's Hospital Medical College | College/University | Doctorate Degree | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Founder | |
| INMUNE BIO, INC. | Biotechnology | Founder | |
| Royal Free Hospital Medical School | College/University | Corporate Officer/Principal | |
| Blizard Institute | College/University | Doctorate Degree | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Founder | |
| Immune Ventures Ltd. | Founder | ||
| Autolomous Ltd. | Founder |
Estadísticas
Internacional
| Reino Unido | 11 |
| Estados Unidos | 2 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 5 |
| Health Services | 2 |
Operativa
| Founder | 6 |
| Corporate Officer/Principal | 5 |
| Director/Board Member | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Mark Lowdell | 12 |
- Bolsa de valores
- Insiders
- Anthony Ting
- Conexiones Empresas